Trial Profile
Brentuximab vedotin-associated pancreatitis in patients with lymphomas
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 May 2014
Price :
$35
*
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Anaplastic large cell lymphoma; Hodgkin's disease
- Focus Adverse reactions
- 17 May 2014 New trial record